Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Nathan

Showing results (111-120 of 245) with videos related to

Pageof 25
Sort By:
Diabetes|November 23, 2013
Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributionsDavid M Nathan, Margaret Bayless, Patricia Cleary, et al.
Diabetes Care|July 29, 2006
Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of DiabetesDavid M Nathan, John B Buse, Mayer B Davidson, et al.
The New England Journal of Medicine|April 20, 2017
Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes, David M Nathan, Ionut Bebu, et al.
Diabetes Care|October 25, 2017
Response to Comment on Lachin et al. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial. Diabetes Care 2017;40:777-783John M Lachin, Ionut Bebu, Richard M Bergenstal, et al.
Diabetes Care|September 18, 2008
Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trialJulie Lin, Robert J Glynn, Nader Rifai, et al.
Archives of Internal Medicine|July 29, 2009
Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005), David M Nathan, Bernard Zinman, et al.
Diabetes Care|March 6, 2007
How doctors choose medications to treat type 2 diabetes: a national survey of specialists and academic generalistsRichard W Grant, Deborah J Wexler, Alice J Watson, et al.
Plos Genetics|December 20, 2008
Novel association of HK1 with glycated hemoglobin in a non-diabetic population: a genome-wide evaluation of 14,618 participants in the Women's Genome Health StudyGuillaume Paré, Daniel I Chasman, Alexander N Parker, et al.
The New England Journal of Medicine|June 6, 2003
Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitusDavid M Nathan, John Lachin, Patricia Cleary, et al.
Diabetes Research and Clinical Practice|December 14, 2020
Moderation of the effect of glycemia on the risk of cardiovascular disease in type 1 diabetes: The DCCT/EDIC studyIonut Bebu, Barbara H Braffett, Trevor J Orchard, et al.
Pageof 25

Showing results (111-120 of 245) with videos related to

Sort By:
Pageof 25
Diabetes|November 23, 2013
Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributionsDavid M Nathan, Margaret Bayless, Patricia Cleary, et al.
Diabetes Care|July 29, 2006
Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of DiabetesDavid M Nathan, John B Buse, Mayer B Davidson, et al.
The New England Journal of Medicine|April 20, 2017
Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes, David M Nathan, Ionut Bebu, et al.
Diabetes Care|October 25, 2017
Response to Comment on Lachin et al. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial. Diabetes Care 2017;40:777-783John M Lachin, Ionut Bebu, Richard M Bergenstal, et al.
Diabetes Care|September 18, 2008
Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trialJulie Lin, Robert J Glynn, Nader Rifai, et al.
Archives of Internal Medicine|July 29, 2009
Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005), David M Nathan, Bernard Zinman, et al.
Diabetes Care|March 6, 2007
How doctors choose medications to treat type 2 diabetes: a national survey of specialists and academic generalistsRichard W Grant, Deborah J Wexler, Alice J Watson, et al.
Plos Genetics|December 20, 2008
Novel association of HK1 with glycated hemoglobin in a non-diabetic population: a genome-wide evaluation of 14,618 participants in the Women's Genome Health StudyGuillaume Paré, Daniel I Chasman, Alexander N Parker, et al.
The New England Journal of Medicine|June 6, 2003
Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitusDavid M Nathan, John Lachin, Patricia Cleary, et al.
Diabetes Research and Clinical Practice|December 14, 2020
Moderation of the effect of glycemia on the risk of cardiovascular disease in type 1 diabetes: The DCCT/EDIC studyIonut Bebu, Barbara H Braffett, Trevor J Orchard, et al.
Pageof 25